Company information lookup

MEDIGARD LIMITED (MGZ)

Development of retractable syringe and other medical device technologies.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
MGZ 0.035 12.9% 0.025 0.040 0.031 0.035 0.031 232,593

ASX Find a broker tool

Helps you find an ASX broker based on your needs and where you live.

MEDIGARD LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code MGZ
Securities
Official Listing Date 5 February, 2004
GICS Industry Group Health Care Equipment & Services
Exempt Foreign? No
Internet Address http://www.medigard.com.au
Registered Office Address Suite 52, Level 5 - HQ, 58 Riverwalk Avenue, ROBINA, QLD, AUSTRALIA, 4226
Head Office Telephone (07) 5578 7822
Head Office Fax (07) 5578 7955
Share Registry BOARDROOM PTY LIMITED
LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Mr Donald Channer (Chairman)
Dr Chris Bishop (Director)
Dr Peter Clark (Non Exec. Director)
Ms Patricia Mary Boero (Associate Director, CFO)
Company Secretary Ms Patricia Mary Boero
Principal Activities Development of retractable syringe and other medical device technologies.

MEDIGARD LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
18/04/2013 asterix Appendix 4C - quarterly 5 PDF
11/04/2013   Appendix 3Y 2 PDF
03/04/2013 asterix Medigard Signs Licence Agreement 2 PDF
27/03/2013   Change of Director's Interest Notice 2 PDF
28/02/2013 asterix Half Yearly Report and Accounts 16 PDF
10/01/2013 asterix Appendix 4C - quarterly 5 PDF
30/11/2012   Results of Meeting 2 PDF
30/11/2012   Chairman's Address to Shareholders 3 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 May 2013 0.035 12.9% 0.035 0.031 232,593
20 May 2013 0.031 6.9% 0.031 0.031 270,000
16 May 2013 0.029 -3.33% 0.029 0.029 16,700
15 May 2013 0.030 -3.23% 0.030 0.030 60,000
08 May 2013 0.031 24% 0.031 0.031 115,000

* Volume of shares shown represents only those shares traded on ASX.

MEDIGARD LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security MGZ. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security MGZ

Warrants & Structured Products

No warrants & Structured Products are available over the security MGZ

ASX CFDs

No Contracts For Differences are available over the security MGZ